The worldwide shortage of donor corneas and postoperative complications present challenges to surgically treating children who are blind from CHED. Therefore, a clearer understanding of disease mechanisms that underlie CHED is needed in an effort to develop alternative treatments (e.g. gene based therapeutics) that will improve patient outcomes and decrease the dependence on donor cornea tissue.
Read More